{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T12:30:04Z","timestamp":1793881804824,"version":"4.7.0"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,10,4]],"date-time":"2017-10-04T00:00:00Z","timestamp":1507075200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,10,4]],"date-time":"2017-10-04T00:00:00Z","timestamp":1507075200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstarct<\/jats:title>\n                  <jats:p>Glaucoma is a chronic disease that shares many similarities with other neurodegenerative disorders of the central nervous system. This study was designed to evaluate the association between glaucoma and other neurodegenerative disorders by investigating glaucoma-associated protein changes in the retina and vitreous humour. The multiplexed Tandem Mass Tag based proteomics (TMT-MS3) was carried out on retinal tissue and vitreous humour fluid collected from glaucoma patients and age-matched controls followed by functional pathway and protein network interaction analysis. About 5000 proteins were quantified from retinal tissue and vitreous fluid of glaucoma and control eyes. Of the differentially regulated proteins, 122 were found linked with pathophysiology of Alzheimer\u2019s disease (AD). Pathway analyses of differentially regulated proteins indicate defects in mitochondrial oxidative phosphorylation machinery. The classical complement pathway associated proteins were activated in the glaucoma samples suggesting an innate inflammatory response. The majority of common differentially regulated proteins in both tissues were members of functional protein networks associated brain changes in AD and other chronic degenerative conditions. Identification of previously reported and novel pathways in glaucoma that overlap with other CNS neurodegenerative disorders promises to provide renewed understanding of the aetiology and pathogenesis of age related neurodegenerative diseases.<\/jats:p>","DOI":"10.1038\/s41598-017-12858-7","type":"journal-article","created":{"date-parts":[[2017,9,28]],"date-time":"2017-09-28T17:06:10Z","timestamp":1506618370000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":129,"title":["Age-related neurodegenerative disease associated pathways identified in retinal and vitreous proteome from human glaucoma eyes"],"prefix":"10.1038","volume":"7","author":[{"given":"Mehdi","family":"Mirzaei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veer B.","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel M.","family":"Chick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd M.","family":"Greco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunqi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitin","family":"Chitranshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roshana Vander","family":"Wall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene","family":"Hone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liting","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yogita","family":"Dheer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mojdeh","family":"Abbasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahdie","family":"Rezaeian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nady","family":"Braidy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyi","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghasem Hosseini","family":"Salekdeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"Haynes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark P.","family":"Molloy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ileana M.","family":"Cristea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven P.","family":"Gygi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart L.","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek K.","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,10,4]]},"reference":[{"key":"12858_CR1","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1167\/iovs.04-0832","volume":"46","author":"L Guo","year":"2005","unstructured":"Guo, L. et al. Retinal ganglion cell apoptosis in glaucoma is related to intraocular pressure and IOP-induced effects on extracellular matrix. Invest Ophthalmol Vis Sci \n                           46, 175\u2013182 (2005).","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"12858_CR2","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1001\/jama.2014.3192","volume":"311","author":"RN Weinreb","year":"2014","unstructured":"Weinreb, R. N., Aung, T. & Medeiros, F. A. The pathophysiology and treatment of glaucoma: a review. JAMA \n                           311, 1901\u20131911 (2014).","journal-title":"JAMA"},{"key":"12858_CR3","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1001\/archopht.120.10.1268","volume":"120","author":"A Heijl","year":"2002","unstructured":"Heijl, A. et al. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol \n                           120, 1268\u20131279 (2002).","journal-title":"Arch Ophthalmol"},{"key":"12858_CR4","doi-asserted-by":"publisher","DOI":"10.1097\/IJG.0b013e3182934af6","volume":"22","author":"JA Ghiso","year":"2013","unstructured":"Ghiso, J. A., Doudevski, I., Ritch, R. & Rostagno, A. A. Alzheimer\u2019s disease and glaucoma: mechanistic similarities and differences. J Glaucoma \n                           22, S36 (2013).","journal-title":"J Glaucoma"},{"key":"12858_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3233\/JAD-2010-100819","volume":"22","author":"S Frost","year":"2010","unstructured":"Frost, S., Martins, R. N. & Kanagasingam, Y. Ocular biomarkers for early detection of Alzheimer\u2019s disease. J Alzheimers Dis \n                           22, 1\u201316 (2010).","journal-title":"J Alzheimers Dis"},{"key":"12858_CR6","doi-asserted-by":"publisher","first-page":"4279","DOI":"10.1007\/s00018-016-2295-x","volume":"73","author":"V Gupta","year":"2016","unstructured":"Gupta, V. et al. One protein, multiple pathologies: multifaceted involvement of amyloid \u03b2 in neurodegenerative disorders of the brain and retina. Cell Mol Life Sci \n                           73, 4279\u20134297 (2016).","journal-title":"Cell Mol Life Sci"},{"key":"12858_CR7","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1126\/science.1141736","volume":"316","author":"ED Roberson","year":"2007","unstructured":"Roberson, E. D. et al. Reducing endogenous tau ameliorates amyloid \u00df-induced deficits in an Alzheimer\u2019s disease mouse model. Science \n                           316, 750\u2013754 (2007).","journal-title":"Science"},{"key":"12858_CR8","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nrneurol.2012.227","volume":"9","author":"A London","year":"2013","unstructured":"London, A., Benhar, I. & Schwartz, M. The retina as a window to the brain\u2014from eye research to CNS disorders. Nat Rev Neurol \n                           9, 44\u201353 (2013).","journal-title":"Nat Rev Neurol"},{"key":"12858_CR9","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1167\/iovs.12-10827","volume":"54","author":"JM Sivak","year":"2013","unstructured":"Sivak, J. M. The Aging Eye: Common Degenerative Mechanisms Between the Alzheimer\u2019s Brain and Retinal Disease Common Degenerative Mechanisms between Brain and Retina. Invest Ophthalmol Vis Sci \n                           54, 871\u2013880 (2013).","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"12858_CR10","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.neulet.2016.04.059","volume":"623","author":"VK Gupta","year":"2016","unstructured":"Gupta, V. K. et al. Amyloid \u03b2 accumulation and inner retinal degenerative changes in Alzheimer\u2019s disease transgenic mouse. Neurosci Lett \n                           623, 52\u201356 (2016).","journal-title":"Neurosci Lett"},{"key":"12858_CR11","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.neulet.2010.06.006","volume":"480","author":"Y Lu","year":"2010","unstructured":"Lu, Y. et al. Retinal nerve fiber layer structure abnormalities in early Alzheimer\u2019s disease: evidence in optical coherence tomography. Neurosci Lett \n                           480, 69\u201372 (2010).","journal-title":"Neurosci Lett"},{"key":"12858_CR12","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/0003-2697(84)90782-6","volume":"138","author":"D Wessel","year":"1984","unstructured":"Wessel, D. & Fl\u00fcgge, U. I. A method for the quantitative recovery of protein in dilute solution in the presence of detergents and lipids. Anal Biochem \n                           138, 141\u2013143 (1984).","journal-title":"Anal Biochem"},{"key":"12858_CR13","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/nmeth.2834","volume":"11","author":"NA Kulak","year":"2014","unstructured":"Kulak, N. A., Pichler, G., Paron, I., Nagaraj, N. & Mann, M. Minimal, encapsulated proteomic-sample processing applied to copy-number estimation in eukaryotic cells. Nat Methods \n                           11, 319\u2013324 (2014).","journal-title":"Nat Methods"},{"key":"12858_CR14","doi-asserted-by":"publisher","first-page":"7150","DOI":"10.1021\/ac502040v","volume":"86","author":"GC McAlister","year":"2014","unstructured":"McAlister, G. C. et al. MultiNotch MS3 enables accurate, sensitive, and multiplexed detection of differential expression across cancer cell line proteomes. Anal Chem \n                           86, 7150\u20137158 (2014).","journal-title":"Anal Chem"},{"key":"12858_CR15","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/nature18270","volume":"534","author":"JM Chick","year":"2016","unstructured":"Chick, J. M. et al. Defining the consequences of genetic variation on a proteome-wide scale. Nature \n                           534, 500\u2013505 (2016).","journal-title":"Nature"},{"key":"12858_CR16","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.cell.2015.06.043","volume":"162","author":"EL Huttlin","year":"2015","unstructured":"Huttlin, E. L. et al. The BioPlex network: a systematic exploration of the human interactome. Cell \n                           162, 425\u2013440 (2015).","journal-title":"Cell"},{"key":"12858_CR17","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/1044-0305(94)80016-2","volume":"5","author":"JK Eng","year":"1994","unstructured":"Eng, J. K., McCormack, A. L. & Yates, J. R. An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database. J Am Soc Mass Spectrom \n                           5, 976\u2013989 (1994).","journal-title":"J Am Soc Mass Spectrom"},{"key":"12858_CR18","doi-asserted-by":"crossref","unstructured":"Elias, J. E. & Gygi, S. P. in Proteome Bioinformatics (eds Simon J. Hubbard & Andrew R. Jones) 55\u201371 (Humana Press, 2010).","DOI":"10.1007\/978-1-60761-444-9_5"},{"key":"12858_CR19","doi-asserted-by":"publisher","first-page":"7469","DOI":"10.1021\/ac301572t","volume":"84","author":"GC McAlister","year":"2012","unstructured":"McAlister, G. C. et al. Increasing the multiplexing capacity of TMTs using reporter ion isotopologues with isobaric masses. Anal Chem \n                           84, 7469\u20137478 (2012).","journal-title":"Anal Chem"},{"key":"12858_CR20","unstructured":"Mirzaei, M. et al. In Proteome Bioinformatics (eds Shivakumar Keerthikumar & Suresh Mathivanan) 45\u201366 (Springer New York, 2017)."},{"key":"12858_CR21","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1046\/j.1432-1327.1999.00725.x","volume":"264","author":"P Bernardi","year":"1999","unstructured":"Bernardi, P., Scorrano, L., Colonna, R., Petronilli, V. & Di Lisa, F. Mitochondria and cell death. Eur J Biochem \n                           264, 687\u2013701 (1999).","journal-title":"Eur J Biochem"},{"key":"12858_CR22","doi-asserted-by":"publisher","DOI":"10.1126\/science.281.5381.1309","volume":"281","author":"DR Green","year":"1998","unstructured":"Green, D. R. & Reed, J. C. Mitochondria and apoptosis. Science \n                           281, 1309 (1998).","journal-title":"Science"},{"key":"12858_CR23","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1016\/j.bbadis.2013.04.014","volume":"1832","author":"V Serre","year":"2013","unstructured":"Serre, V. et al. Mutations in mitochondrial ribosomal protein MRPL12 leads to growth retardation, neurological deterioration and mitochondrial translation deficiency. Biochim Biophys Acta \n                           1832, 1304\u20131312 (2013).","journal-title":"Biochim Biophys Acta"},{"key":"12858_CR24","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1016\/j.bbabio.2011.06.010","volume":"1807","author":"A R\u00f6tig","year":"2011","unstructured":"R\u00f6tig, A. Human diseases with impaired mitochondrial protein synthesis. Biochim Biophys Acta \n                           1807, 1198\u20131205 (2011).","journal-title":"Biochim Biophys Acta"},{"key":"12858_CR25","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/j.exer.2010.03.008","volume":"90","author":"NN Osborne","year":"2010","unstructured":"Osborne, N. N. Mitochondria: their role in ganglion cell death and survival in primary open angle glaucoma. Exp. Eye Res. \n                           90, 750\u2013757 (2010).","journal-title":"Exp. Eye Res."},{"key":"12858_CR26","doi-asserted-by":"publisher","first-page":"839","DOI":"10.3390\/ph3040839","volume":"3","author":"LJ Martin","year":"2010","unstructured":"Martin, L. J. Mitochondrial and cell death mechanisms in neurodegenerative diseases. Pharmaceuticals \n                           3, 839\u2013915 (2010).","journal-title":"Pharmaceuticals"},{"key":"12858_CR27","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/nature05292","volume":"443","author":"MT Lin","year":"2006","unstructured":"Lin, M. T. & Beal, M. F. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature \n                           443, 787\u2013795 (2006).","journal-title":"Nature"},{"key":"12858_CR28","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.bbadis.2009.10.006","volume":"1802","author":"PI Moreira","year":"2010","unstructured":"Moreira, P. I., Carvalho, C., Zhu, X., Smith, M. A. & Perry, G. Mitochondrial dysfunction is a trigger of Alzheimer\u2019s disease pathophysiology. Biochim Biophys Acta \n                           1802, 2\u201310 (2010).","journal-title":"Biochim Biophys Acta"},{"key":"12858_CR29","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1167\/iovs.13-12941","volume":"55","author":"I Doudevski","year":"2014","unstructured":"Doudevski, I. et al. Clusterin and Complement Activation in Exfoliation Glaucoma. Invest Ophthalmol Vis Sci \n                           55, 2491\u20132499 (2014).","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"12858_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-016-0091-6","volume":"11","author":"PA Williams","year":"2016","unstructured":"Williams, P. A. et al. Inhibition of the classical pathway of the complement cascade prevents early dendritic and synaptic degeneration in glaucoma. Mol Neurodegener \n                           11, 26 (2016).","journal-title":"Mol Neurodegener"},{"key":"12858_CR31","doi-asserted-by":"publisher","first-page":"BIO88","DOI":"10.1167\/iovs.17-21809","volume":"58","author":"S Lauwen","year":"2017","unstructured":"Lauwen, S., de Jong, E. K., Lefeber, D. J. & den Hollander, A. I. Omics Biomarkers in OphthalmologyOmics Biomarkers in Ophthalmology. Invest Ophthalmol Vis Sci \n                           58, BIO88\u2013BIO98 (2017).","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"12858_CR32","doi-asserted-by":"publisher","first-page":"5353","DOI":"10.1167\/iovs.13-12245","volume":"54","author":"T Inoue","year":"2013","unstructured":"Inoue, T., Kawaji, T. & Tanihara, H. Elevated Levels of Multiple Biomarkers of Alzheimer\u2019s Disease in the Aqueous Humor of Eyes With Open-Angle GlaucomaAlzheimer\u2019s Disease and OAG. Invest Ophthalmol Vis Sci \n                           54, 5353\u20135358 (2013).","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"12858_CR33","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/0304-3940(89)90843-4","volume":"107","author":"PL McGeer","year":"1989","unstructured":"McGeer, P. L., Akiyama, H., Itagaki, S. & McGeer, E. G. Activation of the classical complement pathway in brain tissue of Alzheimer patients. Neurosci Lett \n                           107, 341\u2013346 (1989).","journal-title":"Neurosci Lett"},{"key":"12858_CR34","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1126\/science.aad8373","volume":"352","author":"S Hong","year":"2016","unstructured":"Hong, S. et al. Complement and microglia mediate early synapse loss in Alzheimer mouse models. Science \n                           352, 712\u2013716 (2016).","journal-title":"Science"},{"key":"12858_CR35","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.mcn.2009.07.013","volume":"43","author":"J-P Liu","year":"2010","unstructured":"Liu, J.-P. et al. Cholesterol involvement in the pathogenesis of neurodegenerative diseases. Mol Cell Neurosci \n                           43, 33\u201342 (2010).","journal-title":"Mol Cell Neurosci"},{"key":"12858_CR36","doi-asserted-by":"publisher","first-page":"5712","DOI":"10.1167\/iovs.09-3655","volume":"50","author":"C Fourgeux","year":"2009","unstructured":"Fourgeux, C. et al. Primary open-angle glaucoma: association with cholesterol 24S-hydroxylase (CYP46A1) gene polymorphism and plasma 24-hydroxycholesterol levels. Invest Ophthalmol Vis Sci \n                           50, 5712\u20135717 (2009).","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"12858_CR37","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/nn0403-345","volume":"6","author":"L Puglielli","year":"2003","unstructured":"Puglielli, L., Tanzi, R. E. & Kovacs, D. M. Alzheimer\u2019s disease: the cholesterol connection. Nat Neurosci \n                           6, 345\u2013351 (2003).","journal-title":"Nat Neurosci"},{"key":"12858_CR38","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1073\/pnas.0305799101","volume":"101","author":"RG Cutler","year":"2004","unstructured":"Cutler, R. G. et al. Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer\u2019s disease. Proc Nat Acad Sci \n                           101, 2070\u20132075 (2004).","journal-title":"Proc Nat Acad Sci"},{"key":"12858_CR39","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1111\/j.1471-4159.2009.06408.x","volume":"111","author":"IJ Martins","year":"2009","unstructured":"Martins, I. J. et al. Cholesterol metabolism and transport in the pathogenesis of Alzheimer\u2019s disease. J Neurochem \n                           111, 1275\u20131308 (2009).","journal-title":"J Neurochem"},{"key":"12858_CR40","doi-asserted-by":"publisher","first-page":"9932","DOI":"10.1523\/JNEUROSCI.3355-05.2005","volume":"25","author":"M Valenza","year":"2005","unstructured":"Valenza, M. et al. Dysfunction of the cholesterol biosynthetic pathway in Huntington\u2019s disease. J. Neurosci. \n                           25, 9932\u20139939 (2005).","journal-title":"J. Neurosci."},{"key":"12858_CR41","doi-asserted-by":"publisher","first-page":"10844","DOI":"10.1523\/JNEUROSCI.0917-10.2010","volume":"30","author":"M Valenza","year":"2010","unstructured":"Valenza, M. et al. Cholesterol defect is marked across multiple rodent models of Huntington\u2019s disease and is manifest in astrocytes. J. Neurosci. \n                           30, 10844\u201310850 (2010).","journal-title":"J. Neurosci."},{"key":"12858_CR42","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1002\/mds.26152","volume":"30","author":"X Huang","year":"2015","unstructured":"Huang, X. et al. Statins, plasma cholesterol, and risk of Parkinson\u2019s disease: a prospective study. Mov Disord \n                           30, 552\u2013559 (2015).","journal-title":"Mov Disord"},{"key":"12858_CR43","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/gim.2015.117","volume":"18","author":"C Van Cauwenberghe","year":"2015","unstructured":"Van Cauwenberghe, C., Van Broeckhoven, C. & Sleegers, K. The genetic landscape of Alzheimer disease: clinical implications and perspectives. Genet Med \n                           18, 421\u2013430 (2015).","journal-title":"Genet Med"},{"key":"12858_CR44","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.jalz.2015.05.009","volume":"11","author":"AJ Saykin","year":"2015","unstructured":"Saykin, A. J. et al. Genetic studies of quantitative MCI and AD phenotypes in ADNI: Progress, opportunities, and plans. Alzheimers Dement. \n                           11, 792\u2013814 (2015).","journal-title":"Alzheimers Dement."},{"key":"12858_CR45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0034078","volume":"7","author":"F Song","year":"2012","unstructured":"Song, F. et al. Plasma apolipoprotein levels are associated with cognitive status and decline in a community cohort of older individuals. PloS one \n                           7, e34078 (2012).","journal-title":"PloS one"},{"key":"12858_CR46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0087017","volume":"9","author":"Q Zhou","year":"2014","unstructured":"Zhou, Q. et al. Association between APOC1 Polymorphism and Alzheimer\u2019s Disease: A Case-Control Study and Meta-Analysis. PloS one \n                           9, e87017 (2014).","journal-title":"PloS one"},{"key":"12858_CR47","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nrneurol.2012.263","volume":"9","author":"C-C Liu","year":"2013","unstructured":"Liu, C.-C., Kanekiyo, T., Xu, H. & Bu, G. Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat Rev Neurol \n                           9, 106\u2013118 (2013).","journal-title":"Nat Rev Neurol"},{"key":"12858_CR48","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/j.1600-0404.1999.tb00724.x","volume":"100","author":"P Caramelli","year":"1999","unstructured":"Caramelli, P. et al. Increased apolipoprotein B serum concentration in Alzheimer\u2019s disease. Acta Neurol Scand. \n                           100, 61\u201363 (1999).","journal-title":"Acta Neurol Scand."},{"key":"12858_CR49","doi-asserted-by":"publisher","first-page":"555","DOI":"10.2217\/clp.10.37","volume":"5","author":"DA Elliott","year":"2010","unstructured":"Elliott, D. A., Weickert, C. S. & Garner, B. Apolipoproteins in the brain: implications for neurological and psychiatric disorders. Clin lipidol \n                           5, 555\u2013573 (2010).","journal-title":"Clin lipidol"},{"key":"12858_CR50","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0150672","volume":"11","author":"PE Khoonsari","year":"2016","unstructured":"Khoonsari, P. E. et al. Analysis of the Cerebrospinal Fluid Proteome in Alzheimer\u2019s Disease. PloS one \n                           11, e0150672 (2016).","journal-title":"PloS one"},{"key":"12858_CR51","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1089\/jop.2013.0239","volume":"30","author":"A Jain","year":"2014","unstructured":"Jain, A., Wordinger, R. J., Yorio, T. & Clark, A. F. Role of the alternatively spliced glucocorticoid receptor isoform GR\u03b2 in steroid responsiveness and glaucoma. J Ocul Pharmacol Ther. \n                           30, 121\u2013127 (2014).","journal-title":"J Ocul Pharmacol Ther."},{"key":"12858_CR52","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1101\/gr.122226.111","volume":"21","author":"JR Tollervey","year":"2011","unstructured":"Tollervey, J. R. et al. Analysis of alternative splicing associated with aging and neurodegeneration in the human brain. Genome Res. \n                           21, 1572\u20131582 (2011).","journal-title":"Genome Res."},{"key":"12858_CR53","doi-asserted-by":"publisher","first-page":"16562","DOI":"10.1073\/pnas.1310249110","volume":"110","author":"B Bai","year":"2013","unstructured":"Bai, B. et al. U1 small nuclear ribonucleoprotein complex and RNA splicing alterations in Alzheimer\u2019s disease. Proc Nat Acad Sci. \n                           110, 16562\u201316567 (2013).","journal-title":"Proc Nat Acad Sci."},{"key":"12858_CR54","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.preteyeres.2006.10.003","volume":"26","author":"UP Andley","year":"2007","unstructured":"Andley, U. P. Crystallins in the eye: function and pathology. Prog Retin Eye Res \n                           26, 78\u201398 (2007).","journal-title":"Prog Retin Eye Res"},{"key":"12858_CR55","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/mp.2016.206","volume":"22","author":"VR Varma","year":"2017","unstructured":"Varma, V. R. et al. Alpha-2 macroglobulin in Alzheimer\u2019s disease: a marker of neuronal injury through the RCAN1 pathway. Mol Psychiatry \n                           22, 13\u201323 (2017).","journal-title":"Mol Psychiatry"},{"key":"12858_CR56","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1001\/archneurol.2012.1282","volume":"69","author":"JD Doecke","year":"2012","unstructured":"Doecke, J. D. et al. Blood-based protein biomarkers for diagnosis of Alzheimer disease. Arch Neurol. \n                           69, 1318\u20131325 (2012).","journal-title":"Arch Neurol."},{"key":"12858_CR57","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1007\/s12035-012-8237-1","volume":"45","author":"J-T Yu","year":"2012","unstructured":"Yu, J.-T. & Tan, L. The role of clusterin in Alzheimer\u2019s disease: pathways, pathogenesis, and therapy. Mol Neurobiol \n                           45, 314\u2013326 (2012).","journal-title":"Mol Neurobiol"},{"key":"12858_CR58","first-page":"27","volume":"3","author":"SE O\u2019Bryant","year":"2016","unstructured":"O\u2019Bryant, S. E. et al. Comparing biological markers of Alzheimer\u2019s disease across blood fraction and platforms: Comparing apples to oranges. Alzheimers Dement \n                           3, 27\u201334 (2016).","journal-title":"Alzheimers Dement"},{"key":"12858_CR59","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0028092","volume":"6","author":"SE O\u2019Bryant","year":"2011","unstructured":"O\u2019Bryant, S. E. et al. A blood-based screening tool for Alzheimer\u2019s disease that spans serum and plasma: findings from TARC and ADNI. PloS one \n                           6, e28092 (2011).","journal-title":"PloS one"},{"key":"12858_CR60","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.exger.2009.09.005","volume":"45","author":"M Ewers","year":"2010","unstructured":"Ewers, M., Mielke, M. M. & Hampel, H. Blood-based biomarkers of microvascular pathology in Alzheimer\u2019s disease. Exp Gerontol \n                           45, 75\u201379 (2010).","journal-title":"Exp Gerontol"},{"key":"12858_CR61","doi-asserted-by":"publisher","DOI":"10.1038\/srep29759","volume":"6","author":"S Funke","year":"2016","unstructured":"Funke, S. et al. Glaucoma related Proteomic Alterations in Human Retina Samples. Sci Rep \n                           6, 29759 (2016).","journal-title":"Sci Rep"},{"key":"12858_CR62","doi-asserted-by":"publisher","first-page":"5071","DOI":"10.1167\/iovs.10-5289","volume":"51","author":"G Tezel","year":"2010","unstructured":"Tezel, G. et al. Oxidative Stress and the Regulation of Complement Activation in Human Glaucoma. Invest Ophthalmol Vis Sci \n                           51, 5071\u20135082 (2010).","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"12858_CR63","first-page":"1825","volume":"47","author":"N Piri","year":"2006","unstructured":"Piri, N., Song, M., Kwong, J. M. K. & Caprioli, J. Expression of Crystallin Genes Is Downregulated in Experimental Glaucoma. Invest Ophth Vis Sci \n                           47, 1825\u20131825 (2006).","journal-title":"Invest Ophth Vis Sci"},{"key":"12858_CR64","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0175451","volume":"12","author":"F Anders","year":"2017","unstructured":"Anders, F. et al. Intravitreal injection of \u03b2-crystallin B2 improves retinal ganglion cell survival in an experimental animal model of glaucoma. PLOS ONE \n                           12, e0175451 (2017).","journal-title":"PLOS ONE"},{"key":"12858_CR65","doi-asserted-by":"publisher","first-page":"8265","DOI":"10.1167\/iovs.12-10334","volume":"53","author":"MRR B\u00f6hm","year":"2012","unstructured":"B\u00f6hm, M. R. R. et al. Crystallin-\u03b2-b2-Overexpressing NPCs Support the Survival of Injured Retinal Ganglion Cells and Photoreceptors in RatsCrystallin-\u03b2-b2-Overexpressing NPCs. Invest Ophthalmol Vis Sci \n                           53, 8265\u20138279 (2012).","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"12858_CR66","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.3727\/096368914X684583","volume":"24","author":"MRR B\u00f6hm","year":"2015","unstructured":"B\u00f6hm, M. R. R. et al. \u03b2B2-Crystallin Promotes Axonal Regeneration in the Injured Optic Nerve in Adult Rats. Cell Transplant \n                           24, 1829\u20131844 (2015).","journal-title":"Cell Transplant"},{"key":"12858_CR67","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/BF00296185","volume":"87","author":"K Renkawek","year":"1994","unstructured":"Renkawek, K., Voorter, C. E., Bosman, G. J., van Workum, F. P. & de Jong, W. W. Expression of alpha B-crystallin in Alzheimer\u2019s disease. Acta Neuropathol \n                           87, 155\u2013160 (1994).","journal-title":"Acta Neuropathol"},{"key":"12858_CR68","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1167\/iovs.05-0830","volume":"47","author":"K Stasi","year":"2006","unstructured":"Stasi, K. et al. Complement component 1Q (C1Q) upregulation in retina of murine, primate, and human glaucomatous eyes. Invest Ophthalmol Vis Sci \n                           47, 1024\u20131029 (2006).","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"12858_CR69","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-8-4","volume":"8","author":"MI Fonseca","year":"2011","unstructured":"Fonseca, M. I. et al. Contribution of complement activation pathways to neuropathology differs among mouse models of Alzheimer\u2019s disease. J neuroinflammation \n                           8, 4 (2011).","journal-title":"J neuroinflammation"},{"key":"12858_CR70","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.pneurobio.2009.01.001","volume":"87","author":"A Salminen","year":"2009","unstructured":"Salminen, A., Ojala, J., Kauppinen, A., Kaarniranta, K. & Suuronen, T. Inflammation in Alzheimer\u2019s disease: amyloid-beta oligomers trigger innate immunity defence via pattern recognition receptors. Prog Neurobiol \n                           87, 181\u2013194 (2009).","journal-title":"Prog Neurobiol"},{"key":"12858_CR71","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1016\/j.bbadis.2014.05.026","volume":"1842","author":"V Gupta","year":"2014","unstructured":"Gupta, V. et al. BDNF impairment is associated with age-related changes in the inner retina and exacerbates experimental glaucoma. Biochim Biophys Acta \n                           1842, 1567\u20131578 (2014).","journal-title":"Biochim Biophys Acta"},{"key":"12858_CR72","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1146\/annurev-neuro-061010-113810","volume":"35","author":"AH Stephan","year":"2012","unstructured":"Stephan, A. H., Barres, B. A. & Stevens, B. The complement system: an unexpected role in synaptic pruning during development and disease. Annu Rev Neurosci \n                           35, 369\u2013389 (2012).","journal-title":"Annu Rev Neurosci"},{"key":"12858_CR73","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/cr.2009.139","volume":"20","author":"JR Dunkelberger","year":"2010","unstructured":"Dunkelberger, J. R. & Song, W.-C. Complement and its role in innate and adaptive immune responses. Cell Res \n                           20, 34\u201350 (2010).","journal-title":"Cell Res"},{"key":"12858_CR74","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/nrneph.2012.195","volume":"8","author":"M Noris","year":"2012","unstructured":"Noris, M., Mescia, F. & Remuzzi, G. STEC-HUS, atypical HUS and TTP are all diseases of complement activation. Nat Rev Nephrol \n                           8, 622\u2013633 (2012).","journal-title":"Nat Rev Nephrol"},{"key":"12858_CR75","doi-asserted-by":"publisher","first-page":"2698","DOI":"10.1161\/01.CIR.0000131660.51520.9A","volume":"109","author":"M Levi","year":"2004","unstructured":"Levi, M., van der Poll, T. & B\u00fcller, H. R. Bidirectional relation between inflammation and coagulation. Circulation \n                           109, 2698\u20132704 (2004).","journal-title":"Circulation"},{"key":"12858_CR76","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.tcm.2005.07.004","volume":"15","author":"M Levi","year":"2005","unstructured":"Levi, M. & van der Poll, T. Two-way interactions between inflammation and coagulation. Trends Cardiovasc Med \n                           15, 254\u2013259 (2005).","journal-title":"Trends Cardiovasc Med"},{"key":"12858_CR77","doi-asserted-by":"crossref","first-page":"599","DOI":"10.3233\/JAD-2012-120820","volume":"32","author":"M Cortes-Canteli","year":"2012","unstructured":"Cortes-Canteli, M., Zamolodchikov, D., Ahn, H. J., Strickland, S. & Norris, E. H. Fibrinogen and altered hemostasis in Alzheimer\u2019s disease. J Alzheimers Dis \n                           32, 599\u2013608 (2012).","journal-title":"J Alzheimers Dis"},{"key":"12858_CR78","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/nrd1330","volume":"3","author":"KJ Barnham","year":"2004","unstructured":"Barnham, K. J., Masters, C. L. & Bush, A. I. Neurodegenerative diseases and oxidative stress. Nat Rev Drug Discov \n                           3, 205\u2013214 (2004).","journal-title":"Nat Rev Drug Discov"},{"key":"12858_CR79","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/S0009-9120(99)00075-2","volume":"32","author":"JM Mat\u00c9s","year":"1999","unstructured":"Mat\u00c9s, J. M., P\u00e9rez-G\u00f3mez, C. & De Castro, I. N. Antioxidant enzymes and human diseases. Clin Biochem \n                           32, 595\u2013603 (1999).","journal-title":"Clin Biochem"},{"key":"12858_CR80","doi-asserted-by":"publisher","first-page":"2685","DOI":"10.1089\/ars.2009.2695","volume":"11","author":"M Mar\u00ed","year":"2009","unstructured":"Mar\u00ed, M., Morales, A., Colell, A., Garc\u00eda-Ruiz, C. & Fern\u00e1ndez-Checa, J. C. Mitochondrial glutathione, a key survival antioxidant. Antioxid Redox Signal \n                           11, 2685\u20132700 (2009).","journal-title":"Antioxid Redox Signal"},{"key":"12858_CR81","first-page":"793","volume":"378","author":"GSH Generally","year":"1997","unstructured":"Generally, G. S. H. Multiple roles of glutathione in the central nervous system. Biol. Chem \n                           378, 793\u2013802 (1997).","journal-title":"Biol. Chem"},{"key":"12858_CR82","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S0014-4835(03)00109-X","volume":"77","author":"M Jansson","year":"2003","unstructured":"Jansson, M., Rada, A., Tomic, L., Larsson, L.-I. & Wadelius, C. Analysis of the Glutathione S-transferase M1 gene using pyrosequencing and multiplex PCR\u2013no evidence of association to glaucoma. Exp Eye Res \n                           77, 239\u2013243 (2003).","journal-title":"Exp Eye Res"},{"key":"12858_CR83","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1136\/bjo.2006.102418","volume":"91","author":"M \u00dcnal","year":"2007","unstructured":"\u00dcnal, M. et al. Glutathione S transferase M1 and T1 genetic polymorphisms are related to the risk of primary open-angle glaucoma: a study in a Turkish population. Br J of ophthalmol \n                           91, 527\u2013530 (2007).","journal-title":"Br J of ophthalmol"},{"key":"12858_CR84","doi-asserted-by":"publisher","first-page":"113","DOI":"10.17219\/acem\/38143","volume":"24","author":"SK \u00c7el\u012fk","year":"2014","unstructured":"\u00c7el\u012fk, S. K. et al. Glutathione S-transferase GSTM 1, null genotype may be associated with susceptibility to age-related cataract. Adv Clin Exp Med \n                           24, 113\u2013119 (2014).","journal-title":"Adv Clin Exp Med"},{"key":"12858_CR85","volume":"8","author":"R Qi","year":"2015","unstructured":"Qi, R., Gu, Z. & Zhou, L. The effect of GSTT1, GSTM1 and GSTP1 gene polymorphisms on the susceptibility of age-related cataract in Chinese Han population. Int J of clinical Exp Med \n                           8, 19448 (2015).","journal-title":"Int J of clinical Exp Med"},{"key":"12858_CR86","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jns.2013.12.018","volume":"338","author":"T Wang","year":"2014","unstructured":"Wang, T. & Wang, B. Association between glutathione S-transferase M1\/glutathione S-transferase T1 polymorphisms and Parkinson\u2019s disease: a meta-analysis. J Neurol Sci \n                           338, 65\u201370 (2014).","journal-title":"J Neurol Sci"},{"key":"12858_CR87","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.neulet.2007.03.024","volume":"418","author":"C Perez-Pastene","year":"2007","unstructured":"Perez-Pastene, C. et al. Association of GST M1 null polymorphism with Parkinson\u2019s disease in a Chilean population with a strong Amerindian genetic component. Neurosci Lett \n                           418, 181\u2013185 (2007).","journal-title":"Neurosci Lett"},{"key":"12858_CR88","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1007\/s12035-015-9092-7","volume":"53","author":"M Wang","year":"2016","unstructured":"Wang, M., Li, Y., Lin, L., Song, G. & Deng, T. GSTM1 null genotype and GSTP1 ILE105Val polymorphism are associated with alzheimer\u2019s disease: A meta-analysis. Mol Neurobiol \n                           53, 1355\u20131364 (2016).","journal-title":"Mol Neurobiol"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-12858-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-12858-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-12858-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T06:40:32Z","timestamp":1671777632000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-12858-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,4]]},"references-count":88,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["12858"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-12858-7","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.731790241.793543616","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,4]]},"assertion":[{"value":"5 June 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"12685"}}